Amgen, maker of Enbrel, was granted the injunction after a judge found that the company was likely to be significantly harmed by the cap
The main practical difference is that orforglipron eliminates injection site reactions entirely, while tirzepatide occasionally causes mild redness or discomfort at the injection site
At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits
Its emergence marks a move toward multi-pathway targeted weight management treatments
Allulose Sweetener This tasty low-calorie sugar alternative doesnt spike blood sugar, supporting metabolic health and reducing symptoms of type 2 diabetes